Cerevel Therapeutics Hldng I shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $6.6M | 157k | 42.40 |
| 2023-09-30 | $2.1M | 97k | 21.83 |
| 2023-06-30 | $5.1M | 161k | 31.79 |
| 2023-03-31 | $4.1M | 163k | 25.16 |
| 2022-12-31 | $4.1M | 131k | 31.45 |
| 2022-06-30 | $1.6M | 59k | 26.43 |
| 2022-03-31 | $1.7M | 48k | 35.26 |
| 2021-12-31 | $1.4M | 43k | 32.22 |
| 2021-03-31 | $36k | 2.6k | 13.66 |